ArticlePharmaceuticals (Basel, Switzerland)2021

A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2).

Paolo Coghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.